Vicarious Surgical (NYSE:RBOT) Trading Up 15.8% – Here’s What Happened

Shares of Vicarious Surgical Inc. (NYSE:RBOT) shot up 15.8% on Wednesday . The company traded as high as $0.2205 and last traded at $0.22. 12,601 shares changed hands during mid-day trading, a decline of 84% from the average session volume of 77,473 shares. The stock had previously closed at $0.19.

Wall Street Analyst Weigh In

Separately, Wall Street Zen downgraded Vicarious Surgical from a “hold” rating to a “sell” rating in a report on Saturday, March 7th. Two investment analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Vicarious Surgical has a consensus rating of “Reduce” and a consensus price target of $7.00.

Vicarious Surgical Price Performance

The company’s fifty day moving average price is $0.61 and its 200 day moving average price is $1.38. The company has a market cap of $1.57 million, a PE ratio of -0.02 and a beta of 1.75.

Institutional Investors Weigh In On Vicarious Surgical

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP boosted its stake in shares of Vicarious Surgical by 22.1% in the 3rd quarter. Dimensional Fund Advisors LP now owns 19,975 shares of the company’s stock worth $110,000 after buying an additional 3,615 shares during the last quarter. Geode Capital Management LLC lifted its holdings in Vicarious Surgical by 26.0% during the fourth quarter. Geode Capital Management LLC now owns 40,494 shares of the company’s stock worth $88,000 after acquiring an additional 8,344 shares during the period. XTX Topco Ltd bought a new stake in Vicarious Surgical during the fourth quarter worth $27,000. Connective Capital Management LLC bought a new stake in Vicarious Surgical during the third quarter worth $169,000. Finally, Jane Street Group LLC purchased a new position in Vicarious Surgical in the fourth quarter worth $98,000. Hedge funds and other institutional investors own 47.27% of the company’s stock.

About Vicarious Surgical

Vicarious Surgical develops a next-generation robotic surgical system that integrates virtual reality (VR) with minimally invasive instrumentation. Its flagship offering combines ultra-slender, articulated robotic arms with a VR surgeon console, allowing physicians to perform laparoscopic procedures with enhanced precision, dexterity and visual immersion. The platform is designed to reduce patient trauma compared with traditional open or laparoscopic surgery and to expand surgeon access to challenging operative sites.

The company’s technology is intended for use across multiple surgical specialties, including general surgery, gynecology and urology.